MA38491B1 - Dihydropyridazine-3,5-dione derivative - Google Patents
Dihydropyridazine-3,5-dione derivativeInfo
- Publication number
- MA38491B1 MA38491B1 MA38491A MA38491A MA38491B1 MA 38491 B1 MA38491 B1 MA 38491B1 MA 38491 A MA38491 A MA 38491A MA 38491 A MA38491 A MA 38491A MA 38491 B1 MA38491 B1 MA 38491B1
- Authority
- MA
- Morocco
- Prior art keywords
- dihydropyridazine
- dione derivative
- prophylactic
- salt
- derivative
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne un dérivé dihydropyridazine-3,5-dione, un de ses sels et des solvates du dérivé et du sel. L'invention concerne également les éléments suivants, lesquels contiennent l'un quelconque desdits composés comme principe actif : un médicament, une composition de médicament, un inhibiteur de transporteur phosphate dépendant du sodium, et un agent prophylactique et/ou thérapeutique ainsi qu'une méthode prophylactique et/ou thérapeutique contre l'hyperphosphatémie, l'hyperparathyroïdisme secondaire et l'insuffisance rénale chronique.The present invention relates to a dihydropyridazine-3,5-dione derivative, a salt thereof and solvates of the derivative and salt. The invention also relates to the following, which contain any of said compounds as an active ingredient: a drug, a drug composition, a sodium-dependent phosphate transporter inhibitor, and a prophylactic and / or therapeutic agent and a prophylactic and / or therapeutic method against hyperphosphatemia, secondary hyperparathyroidism and chronic renal failure.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013051082 | 2013-03-13 | ||
PCT/JP2014/056778 WO2014142273A1 (en) | 2013-03-13 | 2014-03-13 | Dihydropyridazine-3,5-dione derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
MA38491A1 MA38491A1 (en) | 2016-12-30 |
MA38491B1 true MA38491B1 (en) | 2017-09-29 |
Family
ID=56119094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA38491A MA38491B1 (en) | 2013-03-13 | 2014-03-13 | Dihydropyridazine-3,5-dione derivative |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR095394A1 (en) |
MA (1) | MA38491B1 (en) |
-
2014
- 2014-03-13 MA MA38491A patent/MA38491B1/en unknown
- 2014-03-13 AR ARP140100938A patent/AR095394A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
AR095394A1 (en) | 2015-10-14 |
MA38491A1 (en) | 2016-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018015892A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
PH12018500041A1 (en) | Substituted aza compoounds as irak-4 inhibitors | |
PH12015501940A1 (en) | Dihydropyridazine-3,5-dione derivative | |
EA201590224A1 (en) | IMIDAZOTRIASINCARBONITRILE USED AS KINASE INHIBITORS | |
EP3483143A8 (en) | Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer | |
MX352672B (en) | Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer. | |
MD4659B1 (en) | Polymorph of SYK inhibitors | |
MA38039A1 (en) | Céphem compounds substituted in position 2 | |
MA39152B1 (en) | 1,2-substituted cyclopentanes used as orexin receptor antagonists | |
MA47736B1 (en) | Pyrimidopyrimidinones useful as wee-1 kinase inhibitors | |
PH12014502492A1 (en) | Pyrazole compounds as sglt1 inhibitors | |
MX2015010619A (en) | Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer. | |
MA43052B1 (en) | Human Plasma Kallikrein Inhibitors | |
UA110577C2 (en) | Agent for controlling plant diseases, a method for controlling plant diseases and a product for controlling diseases | |
PH12019500370A1 (en) | Triazolopyrazinone derivative useful as a human pde1 inhibitor | |
PH12018500433A1 (en) | Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same | |
GR1008186B (en) | Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof | |
EA201691574A1 (en) | CONDENSED BICYCLIC 2,4-DIAMINOPYRIMIDINE DERIVATIVE AS A DOUBLE ALK AND FAK INHIBITOR | |
ME02299B (en) | Azole derivative | |
MA38491A1 (en) | Dihydropyridazine-3,5-dione derivative | |
EA201690797A1 (en) | NEW CONNECTIONS | |
WO2013165898A3 (en) | Compositions and methods for inhibiting resolvases | |
WO2014149973A3 (en) | Compositions and methods for treating bone diseases | |
MA39719B1 (en) | Pyrazoles substituted with trifluoromethyl as inhibitors of human plasma kallikrein | |
TH134786B (en) | Crystalline form of benzyl benzene inhibitor for SGLT2. |